Successful Reimplantation of Spinal Cord Stimulator One Year after Device Removal Due to Infection
Spinal cord stimulation is an effective treatment modality for patients with numerous pain conditions. Although proven to be highly successful, device implantation does come with some inherent risks. One of the most challenging complications is perioperative infection. For most patients, a simple trial of oral antibiotics and in-office drainage of any superficial infectious material may be sufficient. Deeper infections with wound dehiscence necessitate device removal and intravenous antibiotic therapy. The question remains, if the device was previously providing pain relief for the patient, when is the appropriate time to reimplant the device after the infection has cleared? We describe the case of explantation of an infected device and successful reimplantation after 1 year.
Schwartz, Ruben, DO; Southerland, Warren, MD; Urits, Ivan, MD, interpreted the data and drafted and revised the article.
Kaye, Alan, MD; Viswanath, Omar, MD; Cyrus Yazdi, MD interpreted the data, and drafted and critically revised the article.
Informed consent was provided by the patient for this case report.
Eingereicht: 05. März 2020
Angenommen: 24. August 2020
01. Februar 2021 (online)
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 Song JJ, Popescu A, Bell RL. Present and potential use of spinal cord stimulation to control chronic pain. Pain Physician 2014; 17 (03) 235-246
- 2 Hoelzer BC, Bendel MA, Deer TR. et al. Spinal cord stimulator implant infection rates and risk factors: a multicenter retrospective study. Neuromodulation 2017; 20 (06) 558-562
- 3 Esquer Garrigos Z, Farid S, Bendel MA, Sohail MR. Spinal cord stimulator infection: approach to diagnosis, management, and prevention. Clin Infect Dis 2019; DOI: 10.1093/cid/ciz994.
- 4 Engle MP, Vinh BP, Harun N, Koyyalagunta D. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician 2013; 16 (03) 251-257
- 5 Follett KA, Boortz-Marx RL, Drake JM. et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology 2004; 100 (06) 1582-1594
- 6 Kumar K, Buchser E, Linderoth B, Meglio M, Van Buyten JP. Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts. Neuromodulation 2007; 10 (01) 24-33
- 7 Bedder MD, Bedder HF. Spinal cord stimulation surgical technique for the nonsurgically trained. Neuromodulation 2009; 12 (Suppl. 01) 1-19
- 8 Deer TR, Provenzano DA, Hanes M. et al. The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for infection prevention and management. Neuromodulation 2017; 20 (01) 31-50